Literature DB >> 22370806

[Practical problems by implementation of vaccination recommendations].

C Fendler1, E Saracbasi, F Dybowski, F Heldmann, J Braun.   

Abstract

Patients with inflammatory rheumatic diseases are known to have an increased risk of infections due to the rheumatic disease itself and due to therapy with immunosuppressive agents. The most important procedure to prevent infections is vaccinations, which are usually well-tolerated. The German National Commission for Immunization ( STIKO) has published recommendations for patients with an immunodeficiency. The German Society of Rheumatology (DGRh) has generally implemented these recommendations for patients with chronic inflammatory rheumatic diseases. The immunization status of patients with rheumatic diseases is of increasing importance in routine patient care because some of the recently approved drugs may influence the strength of the immune response to vaccination. However, there is almost no information about the current immunization status and the willingness of patients with rheumatic diseases to undergo vaccination procedures in Germany. There are also no epidemiologic data on the implementation of recommendations for immunization at the level of general practitioners. Here we present the results of a prospective study on the efficacy of standardized recommendations for immunization given to different patient groups with rheumatic diseases treated in a hospital specialized in rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370806     DOI: 10.1007/s00393-011-0946-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  15 in total

1.  Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab.

Authors:  L B S Gelinck; Y K O Teng; G F Rimmelzwaan; B J F van den Bemt; F P Kroon; J M van Laar
Journal:  Ann Rheum Dis       Date:  2007-10       Impact factor: 19.103

2.  [Not Available].

Authors:  A Dippelhofer; C Meyer; P Kamtsiuris; G Rasch; S Reiter; K E Bergmann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2002-04       Impact factor: 1.513

3.  Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study.

Authors:  Daniel A Salmon; Lawrence H Moulton; Saad B Omer; M Patricia DeHart; Shannon Stokley; Neal A Halsey
Journal:  Arch Pediatr Adolesc Med       Date:  2005-05

4.  Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

Authors:  M C Kapetanovic; T Saxne; A Sjöholm; L Truedsson; G Jönsson; P Geborek
Journal:  Rheumatology (Oxford)       Date:  2005-11-15       Impact factor: 7.580

5.  Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy.

Authors:  F Kanakoudi-Tsakalidou; M Trachana; P Pratsidou-Gertsi; E Tsitsami; V Kyriazopoulou-Dalaina
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

6.  [Immunisation coverage in the adult workforce 2003. Utilisation of routine occupational health checks to ascertain vaccination coverage in employees].

Authors:  H-M Bader; P Egler
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2004-12       Impact factor: 1.513

7.  Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.

Authors:  Phillip J Mease; Christopher T Ritchlin; Richard W Martin; Alice B Gottlieb; Scott W Baumgartner; Daniel J Burge; James B Whitmore
Journal:  J Rheumatol       Date:  2004-07       Impact factor: 4.666

Review 8.  [Immunization in children and adolescents with rheumatic diseases].

Authors:  K Minden; M Niewerth; M Borte; W Singendonk; J-P Haas
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

9.  Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.

Authors:  D Albert; J Dunham; S Khan; J Stansberry; S Kolasinski; D Tsai; S Pullman-Mooar; F Barnack; C Striebich; R J Looney; E T Luning Prak; R Kimberly; Y Zhang; R Eisenberg
Journal:  Ann Rheum Dis       Date:  2008-02-04       Impact factor: 19.103

10.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01
View more
  4 in total

1.  [Pneumococcus vaccination in immunosuppressed patients: current recommendations].

Authors:  A Krause; K Krüger
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

2.  Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic.

Authors:  M Krasselt; C Baerwald; O Seifert
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

3.  Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis.

Authors:  A Luque Ramos; F Hoffmann; J Callhoff; A Zink; K Albrecht
Journal:  Rheumatol Int       Date:  2016-07-02       Impact factor: 2.631

4.  [How well are patients with inflammatory rheumatic diseases protected against measles?]

Authors:  U Kiltz; A Celik; S Tsiami; X Baraliakos; I Andreica; D Kiefer; B Bühring; J Braun
Journal:  Z Rheumatol       Date:  2020-09-15       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.